Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Healthcare Triangle (HCTI) Net Income towards Common Stockholders (2020 - 2025)

Historic Net Income towards Common Stockholders for Healthcare Triangle (HCTI) over the last 6 years, with Q3 2025 value amounting to $1.9 million.

  • Healthcare Triangle's Net Income towards Common Stockholders rose 5260.21% to $1.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.5 million, marking a year-over-year increase of 3398.21%. This contributed to the annual value of -$6.0 million for FY2024, which is 3128.02% up from last year.
  • Latest data reveals that Healthcare Triangle reported Net Income towards Common Stockholders of $1.9 million as of Q3 2025, which was up 5260.21% from -$1.4 million recorded in Q2 2025.
  • In the past 5 years, Healthcare Triangle's Net Income towards Common Stockholders ranged from a high of $1.9 million in Q3 2025 and a low of -$9.6 million during Q4 2022
  • Over the past 5 years, Healthcare Triangle's median Net Income towards Common Stockholders value was -$1.7 million (recorded in 2025), while the average stood at -$1.8 million.
  • Per our database at Business Quant, Healthcare Triangle's Net Income towards Common Stockholders crashed by 153507.58% in 2021 and then surged by 16428.2% in 2024.
  • Healthcare Triangle's Net Income towards Common Stockholders (Quarter) stood at -$3.4 million in 2021, then tumbled by 178.71% to -$9.6 million in 2022, then soared by 82.52% to -$1.7 million in 2023, then rose by 19.71% to -$1.3 million in 2024, then surged by 241.39% to $1.9 million in 2025.
  • Its Net Income towards Common Stockholders stands at $1.9 million for Q3 2025, versus -$1.4 million for Q2 2025 and -$1.7 million for Q1 2025.